Table 1.
Leading innovator organizations
| Organization | Products | Location |
|---|---|---|
| Merck | 52 | Darmstadt, Germany |
| Bayer | 52 | Wuppertal, Germany |
| Abbott | 31 | Chicago, USA |
| Hoechst | 29 | Frankfurt, Germany |
| Parke–Davis | 25 | Detroit, USA |
| Schering | 24 | Berlin, Germany |
| Sterling–Winthrop | 25 | Wheeling, USA |
| Roche | 22 | Basel, Switzerland |
| Knoll | 16 | Ludwigshafen, Germany |
| Eli Lilly | 14 | Indianapolis, USA |
| H.K. Mulford | 14 | Philadelphia, USA |
| Merck & Co. | 12 | New York, USA |
The private sector organizations contributing to the largest number of non-FDA-regulated pharmaceutical products (prior to Kefauver-Harris) is indicated, along with the number of new products and the location of the company.